Kaneko M, Horikoshi J
National Cancer Centre Research Institute, Biophysics Division, Tokyo, Japan.
Br J Cancer. 1989 Dec;60(6):880-6. doi: 10.1038/bjc.1989.384.
Effects of nalidixic acid and its derivatives were investigated on mouse cells transformed by methylcholanthrene or an activated c-Ha-ras oncogene. Our findings were as follows. Nalidixic acid preferentially suppressed growth in soft agar of transformed Balb/3T3 mouse cells induced by methylcholanthrene. The suppressive effect of nalidixic acid on growth in soft agar was reversible. Nalidixic acid reversibly reduced saturation density of these transformed cells. Oxolinic acid and pipemidic acid, which are derivatives of nalidixic acid, were less effective than nalidixic acid in suppressing growth in soft agar. Nalidixic acid suppressed growth in soft agar of NIH/3T3 mouse cells transformed by an activated c-Ha-ras, without affecting the amount of ras p21 proteins as detected by an immunoblotting analysis using a monoclonal antibody. These results show that nalidixic acid reversibly suppressed the expression of transformed phenotypes that were already being expressed.
研究了萘啶酸及其衍生物对经甲基胆蒽或活化的c-Ha-ras癌基因转化的小鼠细胞的影响。我们的研究结果如下。萘啶酸优先抑制由甲基胆蒽诱导的转化Balb/3T3小鼠细胞在软琼脂中的生长。萘啶酸对软琼脂中生长的抑制作用是可逆的。萘啶酸可逆地降低了这些转化细胞的饱和密度。萘啶酸的衍生物奥索利酸和吡哌酸在抑制软琼脂中生长方面不如萘啶酸有效。萘啶酸抑制由活化的c-Ha-ras转化的NIH/3T3小鼠细胞在软琼脂中的生长,而使用单克隆抗体通过免疫印迹分析检测到的ras p21蛋白量不受影响。这些结果表明,萘啶酸可逆地抑制了已表达的转化表型的表达。